Solara Active Pharma Sciences partly paid share news and announcements

BSE: 890202Pharmaceuticals & Biotechnology

Trading suspended since 2 Apr 2026

Last traded ₹308.70 on 1 Apr 2026

The company's shares trade as Solara Active Pharma Sciences (SOLARA).

Solara Active Pharma Sciences partly paid share news and announcements

127 announcements, routine notices left out, newest first. Page 2 of 3.

Feb 2026
- 3 Feb · Analysts
  Revised Intimation of Schedule of Analyst / Institutional Investor call under the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, to be held on Friday, February .... (opens in a new tab)
Jan 2026
- 30 Jan · Analysts
  Schedule of Investors/Analysts call to be held on Friday, February 06, 2026 to discuss the Company's unaudited .... (opens in a new tab)
Dec 2025
- 17 Dec · Disclosure
  Allotment of 1,500 shares pursuant to exercise of ESOP options. (opens in a new tab)
- 17 Dec · Reconstitution Of The Management Committee
  Reconstitution of the Management Committee. (opens in a new tab)
- 17 Dec · Management
  Appointment of Mr. Mohanraj S(DIN: 08420411) as Additional Executive Director and Whole Time Director with effect .... (opens in a new tab)
- 5 Dec · Management
  Resignation of Mr. Mohan Muthunarayanan (DIN: 03610282),Whole Time Director & Chief Operating Officer of the .... (opens in a new tab)
- 4 Dec · Legal
  Clarification in relation to the mail received from exchange on December 04, 2025 on Volume Movement. (opens in a new tab)
Nov 2025
Oct 2025
- 30 Oct · Analysts
  Analyst / Investors' call to be held on Wednesday, November 05,2025 at 15.30 P.M. IST, to discuss the Company's .... (opens in a new tab)
- 17 Oct · ESG Rating By CRISIL
  ESG rating received from Crisil ESG Ratings & Analytics Limited. (opens in a new tab)
- 13 Oct · Announcement under Regulation 30 (LODR)-Allotment
  Allotment of shares pursuant to exercise of ESOP Options. (opens in a new tab)
Sep 2025
- 29 Sep · Meeting
  Voting Results and Scrutinizer's Report of the 8th Annual General Meeting. (opens in a new tab)
- 26 Sep · Legal
  Clarification in relation to mail received from BSE on Volume Movement. (opens in a new tab)
- 25 Sep · Meeting
  Solara Active Pharma Sciences Limited - Proceedings of the Eighth Annual General Meeting (opens in a new tab)
- 2 Sep · Business Responsibility and Sustainability Reporting (BRSR)
  Business Responsibility and Sustainability Report for the financial year 2024-25. (opens in a new tab)
- 2 Sep · Meeting
  Dispatch of Notice of 8th Annual General Meeting ("AGM") of the Company. (opens in a new tab)
Aug 2025
- 21 Aug · Intimation Regarding 100 Days Campaign - Saksham Niveshak
  Intimation to shareholders as per the 100 Days Campaign - "Saksham Niveshak". (opens in a new tab)
- 16 Aug · Receipt Of Call Money Pursuant To The First Reminder Notice Issued For Payment Of First Call Money On The Outstanding Partly Paid-Up Rights Equity Shares Of The Company.
  Receipt of first call money pursuant to the First Reminder Notice issued for payment of first call money on .... (opens in a new tab)
- 13 Aug · Business
  Submission of Monitoring Agency Report for the quarter ended June 30, 2025 received from CRISIL Ratings Limited (opens in a new tab)
Jul 2025
- 25 Jul · Business
  Press Release dated July 25, 2025, titled " Solara Q'1 26 Performance" of the Board Meeting held today i.e. .... (opens in a new tab)
- 25 Jul · Business
  There is no Deviation and Variation of Funds raised through Rights issue for Quarter ended June 30, 2025. (opens in a new tab)
- 25 Jul · Board meeting
  Inter alia, to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter .... (opens in a new tab)
- 21 Jul · Analysts
  Schedule of Investors/Analyst call to be held on Friday, 25th July 2025 at 4.00P.M. to discuss the Company's financial .... (opens in a new tab)
- 2 Jul · Dispatch Of First Reminder Notice For Payment Of First Call Money
  Dispatch of First Reminder Notice for payment of First Call Money sent on July 01 2025. (opens in a new tab)
- 1 Jul · Rating
  Credit Rating received from Crisil Ratings Limited (opens in a new tab)
May 2025
- 15 May · Analysts
  Outcome of the Investors' conference call for the quarter ended March 31, 2025 (opens in a new tab)
- 15 May · Management
  Appointment of Internal, Secretarial Auditor and Reappointment of Cost Auditor in the Board Meeting held on May 15, 2025 (opens in a new tab)
- 15 May · Management
  Appointment of Company Secretary, Compliance officer and Key Managerial Personnel (opens in a new tab)
- 15 May · Announcement under Regulation 30 (LODR)-Retirement
  Retirement of Company Secretary and Compliance officer (opens in a new tab)
- 15 May · Management
  Resignation and Appointment of Company Secretary and Compliance officer (opens in a new tab)
- 15 May · Business
  There is no Deviation and Variation of Funds raised through Rights Issue for Quarter ended March 31, 2025 (opens in a new tab)
- 15 May · Business
  Press Release for the Board Meeting held on May 15, 2025 on Q4 of FY 25 (opens in a new tab)
- 15 May · Results
  Inter alia, the Audited standalone and Consolidated Financial Results for the quarter and year ended March 31, .... (opens in a new tab)
- 10 May · Business
  Press release of completion of USFDA Inspection in Ambernath facility. (opens in a new tab)
- 8 May · Analysts
  Conference call scheduled with the investors and analysts on Thursday, May 15, 2025 at 3:30 PM to discuss the .... (opens in a new tab)
- 7 May · Business
  Submission of Monitoring Agency Report for the quarter ended March 31, 2025 received from CRISIL Ratings Limited. (opens in a new tab)
- 5 May · Announcement under Regulation 30 (LODR)-Change in Corporate Office Address
  Change in Corporate Office address. (opens in a new tab)
- 5 May · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
  Change in the Registered Office of the Company within the local limits of the City. (opens in a new tab)
Apr 2025
- 29 Apr · Incorporation Of Wholly Owned Subsidiary Company
  Incorporation of Wholly Owned Subsidiary Company in the name of "Synthix Global Pharma Solutions Limited". (opens in a new tab)
- 9 Apr · Notice On The First Call Money Of The Rights Equity Shares.
  Dispatch of Notice to the eligible shareholders of the First Call Money of the Rights Equity shares (opens in a new tab)
- 2 Apr · Announcement under Regulation 30 (LODR)-Meeting Updates
  Solara Active Pharma Sciences Limited informed the exchange about the outcome of the Rights Issue Committee Meeting held today (i.e.) April 02, 2025 interalia to consider and approve the .... (opens in a new tab)